Fundability SWOT

Strengths (Internal + Positive)	Weaknesses (Internal + Negative)
• Unique chemistry (hydride ions) → IP differentiation, first-mover advantage. • Dendrite-free, non-flammable, safe → clear industrial pull. • Early patents granted + pending. • Alignment with EU decarbonization and hydrogen roadmaps → policy tailwind. • TRL progress already proven in lab (3→4) with validation data.	• Cycle life not yet competitive (>500 cycles needed). • Scale-up challenges for core-shell electrolyte (from grams to kg). • No gigafactory supply chain yet; ecosystem inertia favors lithium. • Small team bandwidth → risk of overextension. • Need for high-purity hydrides = cost-intensive at lab scale.

Opportunities (External + Positive)	Threats (External + Negative)
• TAM >$1T across EV, grid, aerospace, hydrogen. • Industrial venture client pilots (BMW, Airbus, Siemens Energy) → revenue + credibility. • Public funding (BMBF, ZIM, Horizon, IPCEI) available to de-risk TRL 3–6. • R&D tax credits (Forschungszulage) as steady non-dilutive backbone. • Category leadership possible if positioned as post-lithium platform.	• Strong incumbency of Li-ion & Li-solid-state players (CATL, QuantumScape, Toyota). • Investor skepticism: “Another solid-state bet?” risk. • Long time-to-market (8–10 years if not Track A). • Raw material volatility in hydrides (rare-earth supply for cerium). • Policy/market may swing back to lithium dominance if scaling delays persist.

Capital Gap Analysis

Need	Current Capital Readiness	Gap	Impact on Funding Probability	Steps to Close Gap
Electrolyte scale-up (grams → 100 g) Critical Path	Lab-scale synthesis validated; reproducibility shown in coin cells	~€500k for scale-up reactors, gloveboxes, and analytical runs	Without scale-up, cannot provide material for industrial pilots; delays LOIs converting to contracts; investor probability drops by ~40%	Secure venture client pilot (€50–100k each) to co-fund; use Forschungszulage for payroll; bridge with seed VC
Cycle life >500 cycles Performance Validation	100–200 cycles achieved; degradation pathways not stabilized	~€1.5–2M for advanced materials optimization, testing, analytics	Without >500 cycles, no entry into EV/grid pilots; Series A probability reduced by ~50%	Stack industrial testing partnerships (BMW Battery Campus, Airbus D&S); co-develop with Fraunhofer IKTS; raise Series A VC with milestone-based tranches
Pouch cell prototypes (0.5–1 Ah) Demonstrator	Coin-cell prototypes only; no relevant-environment form factor	~€5M for pilot line equipment, packaging, safety testing	Without pouch cells, cannot meet TRL 6; limits strategic interest to “academic curiosity”	Negotiate JDA with OEM/Tier-1 for cost-share; apply BMBF KMU-innovativ only if required by partner; bridge with Series B VC
Industrial pilots (TRL 6 validation) Market Validation	LOIs in discussion; no paid industrial pilots secured	~€1–2M to run first paid demos in aerospace/energy	Without pilots, LOIs remain “soft” → investors discount valuation; exit window slips by 2–3 years	Convert LOIs → paid venture client pilots (€100–300k each); use R&D tax credits to cover in-house work; tie deliverables to acquirer-relevant metrics
Team build-up (ops + scale-up engineers) Operational	Core team = 1 scientist, 1 engineer, 1 business lead; ops & QA missing	~€300–400k/year for 2–3 key hires (scale-up engineer, QA/regulatory, partnerships lead)	Weak ops bandwidth lowers grant evaluator confidence and slows investor diligence; VC views as execution risk	Cover via industrial partner secondments (shared engineers); use VC funds for hires only at TRL 5–6; use grants to finance research staff
IP portfolio expansion (continuations, defensive filings) Legal Protection	2 patents granted, 3 pending	~€150–200k for filings, FTO, continuations	Weak IP reduces M&A attractiveness; exit valuation discount of ~20–30%	Use industrial cost-sharing (partner pays for FTO in their field-of-use); earmark small % of VC round for continuous filings; combine with Fraunhofer patent pool if co-developed
Series A financing (TRL 4–5 → TRL 6) Core Funding	Deck and narrative ready; no lead secured yet	Gap: anchoring lead investor €8–12M	Without lead, syndication fails; delays TRL 6 by 12–18 months	Target deep-tech VCs (HTGF, Vsquared, BlueYard); strengthen case with paid pilots + tax credits as de-risking; position as first hydride solid-state platform